Navigation Links
BRAG Requests that EPA Adopt TSCA Inventory Representation and Equivalency For Renewable and Sustainable Biobased Chemicals
Date:7/27/2018

Representatives of the Biobased and Renewable Products Advocacy Group (BRAG®) and representatives of the Biotechnology Innovation Organization (BIO) met with U.S. Environmental Protection Agency (EPA) staff to discuss the two groups’ recently-issued white paper, “Proposal for a Toxic Substances Control Act (TSCA) Inventory Representation and Equivalency Determinations for Renewable and Sustainable Bio-based Chemicals.” BRAG and BIO members provided a presentation for EPA staff that outlined the regulatory challenges and market impedance facing the biobased industry related to current naming conventions.

TSCA, the U.S. law that regulates both existing and new industrial chemicals introduced for commercial purposes, is interpreted and applied by the U.S. Environmental Protection Agency (EPA) in ways that often make it difficult for new biobased chemicals and, more importantly, their derivatives to enter the market easily if at all. The premarket review process often results in many biobased chemicals being subjected to restrictions beyond those that are applied to chemically identical substances with a petroleum source or those derived from traditional seed and vegetable oils that are already on the market. The source- and process-based TSCA naming system for certain chemicals acts as a significant barrier to the adoption of novel biobased chemicals, hampering commercialization and inviting considerable delays to market entry while taking up more of EPA’s already limited resources.

BRAG and BIO have requested that EPA develop naming guidance for bio-based substances and production sources because current resources are scant, scattered, and dated. Creating comprehensive source- and process-agnostic naming guidance for these chemicals and adopting a constituent-based naming system would level the playing field for biobased chemicals and allow customers more freedom in selecting a greener chemical that is derived from a variety of renewable sources. Any company or organization intending to market biobased products -- whether they come from plants, algae, or restaurant waste -- should read this white paper and join BRAG in the effort to create a more sensible regulatory approach.

For more information, please contact Kathleen Roberts, Executive Director of BRAG, at kroberts@bc-cm.com or (202) 833-6581.

Read the full story at https://www.prweb.com/releases/brag_requests_that_epa_adopt_tsca_inventory_representation_and_equivalency_for_renewable_and_sustainable_biobased_chemicals/prweb15652465.htm.


'/>"/>
Source: PRWeb
Copyright©2018 Vocus, Inc.
All rights reserved


Related biology technology :

1. Lupus Research Institute Requests Strengthened NIH Funding for Biomedical Research in Debilitating Diseases like Lupus
2. Amarantus Requests Rare Pediatric Disease Designation from US FDA for MANF in the Treatment of Retinitis Pigmentosa
3. OARSI Requests that FDA Consider Osteoarthritis as a Serious Disease
4. GSMA: The Adoption Of mHealth Could Reduce Total Annual European Healthcare Spend By Almost Euro 100 Billion In 2017
5. Vitatech Adopts Cinnamon through the American Botanical Councils Adopt-an-Herb Program
6. Multivitamin Direct Adopts InstantGMP-Lite as Their Electronic Batch Record Software
7. Oklahoma State Medicaid Adopts Drug Price Benchmark, PAC
8. InspireMD Secures Financing to Accelerate Advancements in Product Development and Adopts a One Year Stockholder Rights Plan
9. Sanofi Adopts Genedata Biologics for Integrated Biopharma R&D Process Support
10. Ixoreal Biomed "Adopts" Ashwagandha through the American Botanical Council
11. BioNano Genomics Announces the Adoption of Irys System by the Garvan Institute of Medical Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/29/2018)... Calif. (PRWEB) , ... September 29, 2018 , ... ... analytics product enabling mid-level and early-stage companies to access the power of influence ... make our solutions available to a broader market that didn’t necessarily have access ...
(Date:9/27/2018)... ROCHELLE, Va. (PRWEB) , ... September 26, 2018 ... ... announced today that Dr. B. Melina Cimler, a senior quality, regulatory, and in ... life science and FDA-regulated global diagnostic industry has joined the firm as an ...
(Date:9/27/2018)... ... September 26, 2018 , ... Nvision Biomedical ... Pedicle Screw System today at the North American Spine Society (NASS) Annual Meeting, ... Nvision focus Pedicle Screw System, which received clearance from the U.S. Food and ...
(Date:9/24/2018)... (PRWEB) , ... September 24, 2018 , ... ReGrow ... bring the highest quality and most affordable option for hair regrowth in the comfort ... to launch on October 2, 2018. , The sophisticated design and advanced technology ...
Breaking Biology Technology:
(Date:10/3/2018)... Ireland (PRWEB) , ... October ... ... biotechnology company focused on the discovery, development and commercialization of first-in-class stromal ... is being administered to patients with type 2 diabetes and progressive diabetic ...
(Date:10/2/2018)... ... October 02, 2018 , ... Through this webinar, sponsored ... FLIPR screening. They will also learn the role of calcium kinetics in cardiac safety ... chief operations officer at PPSC Biography; and Tsang Wai Lam, an assay development scientist ...
(Date:10/1/2018)... ... October 01, 2018 , ... ... conjugate (ADC) like, lipid based therapeutics, today announced the National Institute of ... the award of first year funding for two separate grants. These two grants ...
Breaking Biology News(10 mins):